TNT launches temperature-controlled transport service
PharmaSafe protects pharmaceuticals and healthcare products across the supply chain in strictly controlled conditions
The company said the service would be suitable for the delivery of medical products such as vaccines and insulin.
TNT said the PharmaSafe service tackles the main challenge facing pharmaceutical supply chains, which is the lack of control and visibility inherent in the involvement of too many middlemen (typically more than 20 for an air shipment).
Risks include damage to packaging, customs clearance delays, and temperature deviations.
TNT said World Health Organisation figures suggest that every fourth vaccine reaches its destination in a degraded state because of incorrect shipping.
The company said PharmaSafe would simplify and secure the international movements of temperature-sensitive pharmaceuticals in strictly controlled conditions.
TNT controls the full supply chain, from packaging procurement to delivery. It uses its own aircraft, handling stations, collection and delivery networks, as well as in-house customs clearance experts.
PharmaSafe uses the va-Q-tainer container from German firm va-Q-tec, which TNT said was one of the best passive containers available.
The containers allow temperatures to be maintained for more than 120 hours without the need for an external power supply or dry ice.
The PharmaSafe system includes real time tracking of location and temperature across the supply chain, with temperatures measured even during flights. The information is transmitted to TNT’s PharmaSafe Management Centre by a GSM transponder that can be used on TNT’s aircraft.
TNT said it could ‘detect, predict and correct any temperature excursion without customers having to take action themselves’.
‘PharmaSafe comes with cutting edge packaging and real time temperature and location tracking to further secure the transport of temperature-controlled pharmaceutical products,’ said Gert de Gier, TNT Express Global Manager, Industry Solutions Healthcare.
PharmaSafe is offered between Europe, the Middle East, Asia and the US, as well as within Europe.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Pharmaceutical
Lessons learned: AstraZeneca’s supply chain resilience during the pandemic
With 26 manufacturing facilities and a global network of more than 250 suppliers, AstraZeneca’s Global Operations Manufacturing footprint is not only large in scale, it's also highly complex and positioned to deliver medicines to patients worldwide
Digital
The human digital twin: a virtual counterpart to the human worker
Several organisations are familiar with making use of digital twin modelling to improve operations. This digitised model typically enables firms to map the physical characteristics of a production environment as well as its processes. But, this mapping process has limitations because it only includes data from machines and not from humans, which are crucial too
Regulatory
How to comply with regulatory expectations to access compliance data for the entire pharmaceutical supply chain
The pharmaceutical supply chain must work and must be known, is not a novel idea. Anyone involved in this industry’s quality processes knows that mastering 100% of its supply chain has been unachievable in the current state-of-the-art… until now!
Digital
Addressing wastage and distribution challenges for a more equitable post-pandemic pharmaceutical industry
When functioning properly, globalised supply chains broaden access to critical medicines for billions of individuals all over the world. Yet, any number of issues, from macro events such as the recent COVID-19 pandemic or the 2010 volcanic eruption in Iceland, through to more simple patient misunderstandings, can lead to expensive and often unnecessary wastage